Volume 24; Issue 3

Main
Investigational New Drugs
Volume 24; Issue 3

Investigational New Drugs

Volume 24; Issue 3

1

Pre-irradiation 9-Amino [20s] camptothecin (9-AC) in patients with newly diagnosed glioblastoma multiforme

Daniel Farray, Manmeet S. Ahluwalia, Josette Snyder, Gene H. Barnett, Bruce H. Cohen, John H. Suh, David M. Peereboom

Journal:

Investigational New Drugs

Year:

2006

Language:

english

File:

PDF, 136 KB

english, 2006

2

Gemcitabine and vinorelbine (GV) versus cisplatin, gemcitabine and vinorelbine (CGV) as first-line treatment in advanced non small cell lung cancer: Results of a prospective randomized phase II study

Emilio Esteban, Joaquin Fra, Yolanda Fernández, Norberto Corral, José M. Vieitez, Isabel Palacio, José L. de Sande, José L. Fernández, Isabel Muñiz, Noemi Villanueva, Enrique Estrada, Beatriz Mareque,

Journal:

Investigational New Drugs

Year:

2006

Language:

english

File:

PDF, 309 KB

english, 2006

3

Suppression of primary breast, colon, gastric and bladder cancers cell growthin vitroby CKBM, a natural product

Wei Zhang, Edgar S. L. Liu, Jun Fu, Hai-Mei Tian, Ying-Jye Wu, Shiu-Fun Pang

Journal:

Investigational New Drugs

Year:

2006

Language:

english

File:

PDF, 246 KB

english, 2006

4

Interferon-α plus capecitabine and thalidomide in patients with metastatic renal cell carcinoma: A pilot study

Robert J. Amato, Anish Rawat

Journal:

Investigational New Drugs

Year:

2006

Language:

english

File:

PDF, 149 KB

english, 2006

5

Phase I and pharmacokinetic study of docetaxel, irinotecan, and celecoxib in patients with advanced non-small cell lung cancer

Athanassios Argiris, Victoria Kut, Lynn Luong, Michael J. Avram

Journal:

Investigational New Drugs

Year:

2006

Language:

english

File:

PDF, 376 KB

english, 2006

6

Flutamide in unresectable pancreatic adenocarcinoma: A randomized, double-blind, placebo-controlled trial

Sanjay Singh Negi, Anil Agarwal, Adarsh Chaudhary

Journal:

Investigational New Drugs

Year:

2006

Language:

english

File:

PDF, 644 KB

english, 2006

7

An open label, non-comparative phase II study of gemcitabine as salvage treatment for patients with pretreated adult type soft tissue sarcoma

J. T. Hartmann, K. Oechsle, J. Huober, A. Jakob, M. Azemar, M. Horger, L. Kanz, C. Bokemeyer

Journal:

Investigational New Drugs

Year:

2006

Language:

english

File:

PDF, 141 KB

english, 2006

8

A Phase I/II study of docetaxel, etoposide, and carboplatin before concurrent chemoradiotherapy with cisplatin and etoposide in limited-stage small cell lung cancer

Patrapim Sunpaweravong, Lyn Magree, Rachel Rabinovitch, Paul Bunn, Karen Kelly

Journal:

Investigational New Drugs

Year:

2006

Language:

english

File:

PDF, 164 KB

english, 2006

9

Phase I trial of oral talactoferrin alfa in refractory solid tumors

Teresa G. Hayes, Gerald F. Falchook, Gauri R. Varadhachary, Dori P. Smith, Lisa D. Davis, Hari M. Dhingra, Benjamin P. Hayes, Atul Varadhachary

Journal:

Investigational New Drugs

Year:

2006

Language:

english

File:

PDF, 220 KB

english, 2006

10

Cytotoxicity of sphingoid marine compound analogs in mono- and multilayered solid tumor cell cultures

José M. Padrón, Godefridus J. Peters

Journal:

Investigational New Drugs

Year:

2006

Language:

english

File:

PDF, 923 KB

english, 2006

11

Phase I study of Vinflunine administered as a 10-minute infusion on days 1 and 8 every 3 weeks

Peter Johnson, Thomas Geldart, Pierre Fumoleau, Marie-Claire Pinel, Laurent Nguyen, Ian Judson

Journal:

Investigational New Drugs

Year:

2006

Language:

english

File:

PDF, 696 KB

english, 2006

12

Phase II study of interferon-alpha and doxycycline for advanced renal cell carcinoma

Michael Huie, Kurt Oettel, Lynn Van Ummersen, Kyung Mann Kim, Yulin Zhang, Mary Jane Staab, Dottie Horvath, Rebecca Marnocha, Jeff Douglas, Amy Drezen, Dona Alberti, George Wilding

Journal:

Investigational New Drugs

Year:

2006

Language:

english

File:

PDF, 138 KB

english, 2006